Sangamo Therapeutics, Inc.

Sangamo has developed a range of capabilities that enable them to address serious and life-threatening genetic diseases with the appropriate therapeutic approach. These include best-in-class capabilities in gene therapy and genome editing, which are being deployed to produce therapeutic proteins from the liver and to generate new types of cell-based therapies.  Sangamo can also regulate genes for therapeutic benefit.